Managing Dentine Hypersensitivity With Silver Diamine Fluoride on Older Adults

July 23, 2023 updated by: Chun Hung Chu, The University of Hong Kong

A Clinical Protocol on the Effectiveness of 38% Silver Diamine Fluoride in Reducing Dentine Hypersensitivity on Exposed Root Surface in Older Chinese Adults

Background: Dentine hypersensitivity is a common oral complaint from older adults. It induces pain, affects oral hygiene practice, limits food choices and negatively affects the quality of life. Silver diamine fluoride (SDF) is a desensitizing agent but well-designed clinical trials are lacking. The objective of this study is to evaluate the effectiveness of SDF in reducing dentine hypersensitivity in older Chinese adults.

Methods: This is a double-blinded randomised clinical trial recruiting 166 healthy older adults aged 65 or over after having written consent. A trained calibrated examiner will conduct clinical examination and assess dentine hypersensitive using a blast of compressed air delivered from 3-in-1 syringe. Older adults with a tooth with a self-perceived sensitivity score (SS) of 8 or above will be recruited. They will then be block randomised to receive either 38% SDF solution or 5% potassium nitrate every 4 weeks on the exposed root surface of the most hypersensitive tooth. The visible plaque index, bleeding on probing and probing depth (mm) will be recorded on the most hypersensitive tooth. The same examiner will perform clinical examination and assess the dentine hypersensitivity using the same tools and methods at 4-week and 8-week follow-ups. The examiner and older adults will be blinded to treatment allocation. The primary outcome is the percentage of change in SS before and after intervention at 8 weeks. The secondary outcome will be the percentage of change in VPI before and after intervention at 8 weeks.

Clinical significance: It will provide evidence to manage dentine hypersensitivity in older adults in clinical care.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

166

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Chun Hung Chu, PhD
  • Phone Number: (+852)28590287
  • Email: chchu@hku.hk

Study Locations

      • Hong Kong, China
        • Recruiting
        • The University of Hong Kong
        • Contact:
          • Chun Hung Chu
          • Phone Number: 00852-28590287
          • Email: chchu@hku.hk

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 100 years (Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • generally healthy;
  • no known or suspected allergy to the study ingredients or materials
  • have all active dental diseases under control but reported hypersensitivity

Exclusion Criteria:

  • using any desensitizing agent within one month
  • have major systemic diseases such as cancer
  • receive medications that may affect pain perception within one month
  • have dentine hypersensitivity due to other dental conditions such as caries
  • are not able to give written consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: SDF
38% silver diamine fluoride solution
38% silver diamine fluoride solution
Active Comparator: KNO3
5% potassium nitrate solution
5% potassium nitrate solution

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in dentine hypersensitivity
Time Frame: at 8-week follow-up
the percentage of change in self-perceived sensitivity score (SS)
at 8-week follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in oral hygiene status
Time Frame: at 8-week follow-up
the percentage of change in visible plaque index
at 8-week follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2023

Primary Completion (Estimated)

November 30, 2023

Study Completion (Estimated)

February 28, 2024

Study Registration Dates

First Submitted

May 22, 2022

First Submitted That Met QC Criteria

May 22, 2022

First Posted (Actual)

May 26, 2022

Study Record Updates

Last Update Posted (Actual)

July 25, 2023

Last Update Submitted That Met QC Criteria

July 23, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • HKU2022

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dentine Hypersensitivity

Clinical Trials on SDF

3
Subscribe